Navigation Links
Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
Date:10/3/2007

NEW CANAAN, Conn., Oct. 3 /PRNewswire-FirstCall/ -- Marshall Edwards, Inc. (Nasdaq: MSHL) will present at the BIO Investor Forum 2007 at the San Francisco Palace Hotel on Thursday, October 11, 2007 at 12:00 pm.

About Marshall Edwards, Inc.

Marshall Edwards, Inc. (Nasdaq: MSHL) is a specialist oncology company focused on the clinical development of novel anti-cancer therapeutics. These derive from a flavonoid technology platform which has generated a number of novel compounds characterized by broad ranging efficacy against a range of cancer targets with few side effects. The unique combination of efficacy and safety has been explained by their ability to target an enzyme present on the surface of cancer cells, thereby inhibiting the production of pro-survival proteins within the cell. Marshall Edwards, Inc. has licensed rights from Novogen Limited (Nasdaq: NVGN) to bring three oncology drugs -- phenoxodiol, NV-196 and NV-143 -- to market globally. The Company's lead investigational drug, phenoxodiol, is in a Phase III multinational multi-centered clinical trial for patients with recurrent ovarian cancer. More information on the trial can be found at http://www.OVATUREtrial.
'/>"/>

SOURCE Marshall Edwards, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... (PRWEB) May 16, 2013 In late 2012, ... to speak to doctors in China about Appearance Medicine ... NZ, this was her first trip to lecture in China, ... visited Guangzhou and Fuzhou, home to 12 and 7 million ... is very high at this point in time. As Dr. ...
(Date:5/16/2013)... , May 16, 2013  HealthSparq, a trusted ... the nation,s largest regional health plans, will debut ... Insurance Plans (AHIP) Institute 2013 conference on June ... results showing how health insurance companies across the ... consumer and marketplace demands for increased healthcare transparency. ...
(Date:5/16/2013)... On average, developing a new drug takes ... Despite this investment, less than 10% of drugs make ... clinical trial design optimally structured to balance time, cost ... Frederic Sax, Global Head of the Center for Drug ... information and technology in upfront clinical trial planning and ...
(Date:5/16/2013)... DNA Genotek, a leading provider of products ... sponsorship program in conjunction with the African Society of Human ... and reduce the cost of DNA collection for ... Heredity and Health in Africa (H3 Africa) Initiative and to ... of the AfSHG is to build the capacity ...
Breaking Biology Technology:HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2DNA Genotek Inc. Announces Spit for Africa Program 2DNA Genotek Inc. Announces Spit for Africa Program 3
... ... ... ... ...
... ... production, Zap-Hybridoma improves target antibody purity and hybridoma productivity. , ... Fort Collins, CO (PRWEB) ... hybridoma cell culture. Zap-Hybridoma was created to improve monoclonal antibody productivity and ...
... ... announced today that Michelle Flewell, the company’s Vice President of eLearning ... to serve on the Certificate Accreditation Program Advisory Council. Flewell will ... with developing policies and procedures for ICE accreditation of assessment-based certificate ...
Cached Biology Technology:VIVUS to Present at Two Upcoming Investor Conferences 2VIVUS to Present at Two Upcoming Investor Conferences 3InVitria Optimizes Hybridoma Cell Culture with New Product Zap-Hybridoma 2InVitria Optimizes Hybridoma Cell Culture with New Product Zap-Hybridoma 3BioSoteria eLearning Executive Michelle Flewell Selected for Accreditation Council 2BioSoteria eLearning Executive Michelle Flewell Selected for Accreditation Council 3
(Date:5/16/2013)... Access to Research Careers) Program has announced the ... 95th Annual Meeting in San Francisco, CA from ... promote the entry of students, postdoctorates and scientists ... basic science community and to encourage the participation ... Meeting. , Awards are given to poster/platform presenters ...
(Date:5/16/2013)... For decades, scientists have used ancient shorelines to predict the ... Markings of a high shoreline from three million years ago, ... period were thought to be evidence of a high ... This assumption has led many scientists to think that if ... they may do just the same in our modern, progressively ...
(Date:5/16/2013)... the cellular layer lining the body,s blood vessels, ... nanometers in thickness, this super-tenuous structure routinely withstands ... to create a unique and highly dynamic barrier ... from the body,s circulatory system. , It,s also ... be physically breached to enable immune cells ...
Breaking Biology News(10 mins):World's biggest ice sheets likely more stable than previously believed 2Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4
... just 9.8 kilobases, the HIV genome pales in comparison ... primate targets. The compact retrovirus encodes just 14 proteins, ... virulence. As a retrovirus, HIV uses the host’s cellular ... RNA genome into DNA and infiltrate human chromosomal DNA. ...
... high-tech microscope will be brought to the marketplace, ... organisms. EMBLEM Technology Transfer GmbH (EMBLEM), the commercial ... announced today that it has signed a licensing ... a new technology called SPIM (Selective Plane Illumination ...
... a pretty good handle on how to teach human cells ... from the mouth's lining to form bone. , But in ... the jaw bone of a person undergoing radiation therapy for ... mouth as well as compensating for the damage of radiation. ...
Cached Biology News:Novel Enzyme Shows Potential As An Anti-HIV Target 2Novel Enzyme Shows Potential As An Anti-HIV Target 3The transparent organism: EMBLEM and Carl Zeiss give labs a unique look at life 2U-M scientist to talk about tissue engineering at AAAS 2